Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 1
2013 2
2020 1
2021 3
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.
Willekens C, Laplane L, Dagher T, Benlabiod C, Papadopoulos N, Lacout C, Rameau P, Catelain C, Alfaro A, Edmond V, Signolle N, Marchand V, Droin N, Hoogenboezem R, Schneider RK, Penson A, Abdel-Wahab O, Giraudier S, Pasquier F, Marty C, Plo I, Villeval JL, Constantinescu SN, Porteu F, Vainchenker W, Solary E. Willekens C, et al. Among authors: edmond v. Leukemia. 2023 Jun;37(6):1287-1297. doi: 10.1038/s41375-023-01878-0. Epub 2023 Apr 26. Leukemia. 2023. PMID: 37100881
Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms.
Courdy C, Platteeuw L, Ducau C, De Araujo I, Boet E, Sahal A, Saland E, Edmond V, Tavitian S, Bertoli S, Cougoul P, Granat F, Poillet L, Marty C, Plo I, Sarry JE, Manenti S, Mansat-De Mas V, Joffre C. Courdy C, et al. Among authors: edmond v. Blood Cancer J. 2023 Jul 10;13(1):106. doi: 10.1038/s41408-023-00875-x. Blood Cancer J. 2023. PMID: 37423955 Free PMC article.
In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target.
Murakami S, Barroca V, Perié L, Bravard A, Bernardino-Sgherri J, Tisserand A, Devanand C, Edmond V, Magniez A, Tenreira Bento S, Torres C, Pasquier F, Plo I, Vainchenker W, Villeval JL, Roméo PH, Lewandowski D. Murakami S, et al. Among authors: edmond v. Blood Cancer Discov. 2022 Jul 6;3(4):285-297. doi: 10.1158/2643-3230.BCD-21-0039. Blood Cancer Discov. 2022. PMID: 35290450 Free PMC article. Retracted.
Dual role of EZH2 in megakaryocyte differentiation.
Mazzi S, Dessen P, Vieira M, Dufour V, Cambot M, El Khoury M, Antony-Debré I, Arkoun B, Basso-Valentina F, BenAbdoulahab S, Edmond V, Rameau P, Petermann R, Wittner M, Cassinat B, Plo I, Debili N, Raslova H, Vainchenker W. Mazzi S, et al. Among authors: edmond v. Blood. 2021 Oct 28;138(17):1603-1614. doi: 10.1182/blood.2019004638. Blood. 2021. PMID: 34115825 Free PMC article.
PPARγ agonists promote the resolution of myelofibrosis in preclinical models.
Lambert J, Saliba J, Calderon C, Sii-Felice K, Salma M, Edmond V, Alvarez JC, Delord M, Marty C, Plo I, Kiladjian JJ, Soler E, Vainchenker W, Villeval JL, Rousselot P, Prost S. Lambert J, et al. Among authors: edmond v. J Clin Invest. 2021 Jun 1;131(11):e136713. doi: 10.1172/JCI136713. J Clin Invest. 2021. PMID: 33914703 Free PMC article.
Precise mapping of the CD95 pre-ligand assembly domain.
Edmond V, Ghali B, Penna A, Taupin JL, Daburon S, Moreau JF, Legembre P. Edmond V, et al. PLoS One. 2012;7(9):e46236. doi: 10.1371/journal.pone.0046236. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049989 Free PMC article.
Exacerbation of thrombo-inflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.
Bourrienne MC, Le Cam Duchez V, Faille D, Farkh C, Solo Nomenjanahary M, Gay J, Loyau S, Journé C, Dupont S, Ollivier V, Villeval JJ, Plo I, Edmond V, Jandrot-Perrus M, Labrouche-Colomer S, Cassinat B, Verger E, Desilles JP, Ho Tin Noé BH, Triquenot Bagan A, Mazighi M, Ajzenberg N. Bourrienne MC, et al. Among authors: edmond v. Blood Adv. 2024 Feb 22:bloodadvances.2023011692. doi: 10.1182/bloodadvances.2023011692. Online ahead of print. Blood Adv. 2024. PMID: 38386979
14 results